With AI-powered predictive healthcare, Humn Health aims to make maternal care proactive

Healthcare today operates on a reactive model where medical intervention begins only after symptoms appear. Patients often receive diagnoses without prior warning, and physicians prescribe medications based on population averages rather than individual biological profiles, adjusting dosages through trial and error. 

India sees over 25 million pregnancies annually, with maternal complications contributing to preventable health burdens. Conditions like gestational diabetes and preeclampsia carry long-term health implications, with the current healthcare systems lacking predictive capabilities to identify and address these risks before they develop.

Humn Health was founded in 2024 to address these gaps through predictive AI technology. CEO Himalesh Kumar, a serial entrepreneur whose previous AI and IoT startup Tapdn was acquired by Berkshire Hathaway, recognised the potential for AI-driven healthcare while caring for his ailing father. 

He founded the company along with COO Alok Soni, who brings experience in strategy and growth operations; Ted Chang, a computer science executive who has worked with the United States Department of Defence; and chief AI officer Dr Joshua Chang, who holds a PhD in Biomathematics and spent several years at the National Institutes of Health developing machine learning systems for healthcare applications.

The solution 

Humn Health has developed an adaptive AI foundation model that integrates biological, environmental, and behavioural signals to forecast health risks and tailor interventions. “Our goal is to move healthcare from reactive treatment to proactive, precision-driven care,” Kumar tells YourStory.

It taps into smartphone cameras and utilises them as continuous health sensors using remote photoplethysmography (rPPG), computer vision, and proprietary machine learning models. These cameras capture physiological signals and stream them into predictive algorithms operating in the background.

The healthtech startup currently operates a test market as part of its research and development phase and expects to launch widely within the next few months. Initially, it will focus on maternal care in India, offering predictive medical care for fertility, gestational diabetes, preeclampsia, eclampsia, and anaemia. Its system identifies these risks by analysing biomarkers before conception and symptom onset, providing actionable recommendations based on patients' age, health conditions, and geographic location.

It integrates with smartphones, wearables like the Oura Ring and Apple Watch, and clinical devices into a single ecosystem. “Humn Health acts as the glue connecting hardware and healthcare,” Kumar says. Data is then fed into its predictive models, enabling continuous monitoring of health and environmental metrics such as air quality. The system alerts users only when action is required and provides physicians with real-time intelligence to support informed clinical decisions.

Tech build and go-to-market plan

Humn Health’s foundation model was trained over 18 months using electronic health records from the National Institutes of Health, Massachusetts General Hospital, UMass, and datasets from Europe and India. This global approach distinguishes it from region-specific solutions.

Its competitors include US-based companies like Hims & Hers and Roman, and India-based players including JioVio Healthcare and Kriya by Empathy Design Labs. However, it positions itself as a first line of defence that subsequently connects users to traditional healthcare providers like Apollo and Cloud Nine. 

“The ultimate vision is to serve anyone who wants to consume healthcare in a smart, intelligent, effortless, frictionless way while reducing costs,” Kumar says. 

The Bengaluru-based startup targets users seeking affordable, accessible healthcare, starting with expectant and aspiring parents, offering a B2C freemium model with free basic consultations, which will cost around Rs 100 to Rs 500 and a paid tier for tests and advanced services. On the B2B side, it aims to run on a pure SaaS model, with large hospital chains as clients.

Funding and the roadmap ahead

Humn Health has raised Rs. 4.2 crore in pre-seed funding, backed by US Angels. Following its maternal care launch in India, the company plans to expand into broader male and female health, addressing chronic and lifestyle-linked conditions, hormonal health, and preventive wellness. 

“We envision transforming how the next generation consumes healthcare, making Humn Health the first service people think of when considering their health needs, then seamlessly connecting them to traditional providers with richer data and insights,” Kumar says.

Humn Health is part of YourStory’s Tech30 cohort—a selection of India’s most promising startups of 2025—unveiled at TechSparks Bengaluru.